{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:08:03Z","timestamp":1777867683986,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 MH018399"],"award-info":[{"award-number":["T32 MH018399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 DA26306"],"award-info":[{"award-number":["P50 DA26306"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA04499"],"award-info":[{"award-number":["R01 DA04499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.pnpbp.2020.110089","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:21:01Z","timestamp":1599211261000},"page":"110089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine"],"prefix":"10.1016","volume":"106","author":[{"given":"T. Jordan","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Milienne-Petiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Deben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Grelotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2020.110089_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881103017001700","article-title":"The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat","volume":"17","author":"Abdul-Monim","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0010","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/npp.2008.41","article-title":"Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen","volume":"33","author":"Arai","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","article-title":"Sensorimotor gating and schizophrenia. Human and animal model studies","volume":"47","author":"Braff","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13803390490510031","article-title":"Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection","volume":"26","author":"Carey","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.brs.2011.04.004","article-title":"Effects of repeated electroconvulsive shock on methamphetamine-induced behavioral abnormalities in mice","volume":"5","author":"Chao","year":"2012","journal-title":"Brain Stimul."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10461-010-9869-7","article-title":"Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008","volume":"16","author":"Clark","year":"2012","journal-title":"AIDS Behav."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/QAD.0b013e3280114a29","article-title":"Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance","volume":"21","author":"Colfax","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jpsychires.2008.06.004","article-title":"Prepulse inhibition of startle in adults with ADHD","volume":"43","author":"Feifel","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijdevneu.2006.02.001","article-title":"Neonatal hippocampal tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response","volume":"24","author":"Fitting","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2006.07.014","article-title":"Neonatal intrahippocampal gp120 injection: an examination early in development","volume":"28","author":"Fitting","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hipo.20376","article-title":"Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study","volume":"18","author":"Fitting","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03033358","article-title":"The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?","volume":"10","author":"Geyer","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyg.2019.00103","article-title":"The importance of sensory processing in mental health: a proposed addition to the research domain criteria (RDoC) and suggestions for RDoC 2.0","volume":"10","author":"Harrison","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0075","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s10461-016-1584-6","article-title":"Prevalence and predictors of substance use disorders among HIV care Enrollees in the United States","volume":"21","author":"Hartzler","year":"2017","journal-title":"AIDS Behav."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/FBP.0000000000000012","article-title":"Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine","volume":"25","author":"Henry","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0085","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/npp.2015.39","article-title":"Methamphetamine exposure combined with HIV-1 disease or gp120 expression: comparison of learning and executive functions in humans and mice","volume":"40","author":"Kesby","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbi.2017.05.004","article-title":"HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function","volume":"65","author":"Kesby","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2018.04.046","article-title":"Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice","volume":"349","author":"Kesby","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00635-8","article-title":"Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice","volume":"316","author":"Kuribara","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0105","first-page":"168","article-title":"Doxycycline-inducible and astrocyte-specific HIV-1 tat transgenic mice (iTat) as an HIV\/neuroAIDS model","volume":"24","author":"Langford","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(01)00561-5","article-title":"Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone","volume":"69","author":"Mansbach","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.psychres.2013.11.004","article-title":"\u201cFrontal systems\u201d behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency","volume":"215","author":"Marquine","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-virology-101416-041703","article-title":"Humanized mouse models for human immunodeficiency virus infection","volume":"4","author":"Marsden","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2006.08.006","article-title":"The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients","volume":"89","author":"Minassian","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S1355617713000301","article-title":"Prepulse inhibition in HIV-associated neurocognitive disorders","volume":"19","author":"Minassian","year":"2013","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.drugalcdep.2017.01.035","article-title":"Everyday functional ability in HIV and methamphetamine dependence","volume":"175","author":"Minassian","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(01)01184-2","article-title":"Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania","volume":"50","author":"Perry","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-0327(03)00157-5","article-title":"Prepulse inhibition in patients with non-psychotic major depressive disorder","volume":"81","author":"Perry","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2005.09.025","article-title":"Sensorimotor gating deficits in adults with autism","volume":"61","author":"Perry","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","article-title":"Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis","volume":"80","author":"Potvin","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0160","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.euroneuro.2016.11.016","article-title":"The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia","volume":"27","author":"Prades","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/09540120310001618621","article-title":"Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men","volume":"15","author":"Reback","year":"2003","journal-title":"AIDS Care"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","article-title":"Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons","volume":"10","author":"Rippeth","year":"2004","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0175","first-page":"156","article-title":"Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research","volume":"24","author":"Thaney","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0180","series-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.pnpbp.2020.110089_bb0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/13803395.2017.1349879","article-title":"HIV-associated executive dysfunction in the era of modern antiretroviral therapy: a systematic review and meta-analysis","volume":"40","author":"Walker","year":"2018","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.pnpbp.2020.110089_bb0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1037\/a0036425","article-title":"Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia","volume":"128","author":"Young","year":"2014","journal-title":"Behav. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462030405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462030405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:41:15Z","timestamp":1777545675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462030405X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":38,"alternative-id":["S027858462030405X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110089","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.11.130666","asserted-by":"object"}]},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110089"}}